Dig Dis Sci: 小肠血管扩张症再出血和高危患者的鉴定方法

2021-01-14 MedSci原创 MedSci原创

2001年以后,小肠胶囊内镜(SBCE)已在小肠病变的调查得到普及,而且小肠胶囊内镜检查(SBCE)是检查可疑性小肠出血(SBB)的金标准。

      2001年以后,小肠胶囊内镜(SBCE)已在小肠病变的调查得到普及,而且小肠胶囊内镜检查(SBCE)是检查可疑性小肠出血(SBB)的金标准。血管扩张是胃肠道中最常见的血管异常,据报道在多达80%的SBB患者中,血管扩张是其肠道出血的主要原因。这项研究的目的是确定SBCE中存在小肠血管扩张的患者再出血的一些特征和可能的独立预测因子。

 

 

      本项研究是一项回顾性研究,包括了在2008年4月至2017年12月期间进行SBCE检查并伴有血管扩张的患者,所有患者均至少随访12个月。再出血的定义是血红蛋白下降≥2 g/dl和/或在存在食管胃十二指肠镜检查和回肠结肠镜发现肠道出血的现象。研究人员从病历中收集临床数据,并按数量,位置,大小和类型对血管扩张进行分类。进行单变量和多变量统计分析,以确定可能的再出血预测因素。

 

 

      本项研究中共纳入630名因怀疑SBB而进行SBCE检查的患者,其中129名患有血管扩张的患者。女性占59.7%,中位年龄为72(19-91)岁,平均随访44.0±31.9个月。在32.6%(n  = 42)的患者中,至少记录了一次再出血。存在心力衰竭(OR 3.41; 95%CI 1.18–9.89; p  = 0.024),血管扩张程度(OR 5.41; 95%CI 2.15-13.6; p  <0.001)和吸烟状态(OR 3.15; 95%CI 1.07–9.27;p  = 0.038)是再出血的独立预测因素。

 

 

 

      通过本项研究作者发现心力衰竭,吸烟状态和大小超过5毫米的血管扩张是SBCE诊断的血管扩张人群再出血的独立预测因素。

 

 

原始出处:

Cátia Arieira. Et al. Small Bowel Angioectasias Rebleeding and the Identification of Higher Risk Patients. Digestive Diseases and Sciences.2021.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1705687, encodeId=20eb1e0568783, content=<a href='/topic/show?id=ac7e89660ed' target=_blank style='color:#2F92EE;'>#血管扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89660, encryptionId=ac7e89660ed, topicName=血管扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cbe31021348, createdName=pyaili, createdTime=Wed Apr 07 20:53:10 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013562, encodeId=12b4201356248, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Oct 24 19:53:10 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684854, encodeId=0885168485451, content=<a href='/topic/show?id=794754e74f4' target=_blank style='color:#2F92EE;'>#扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54774, encryptionId=794754e74f4, topicName=扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=699d28086811, createdName=lsj637, createdTime=Sun Jan 17 20:53:10 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955788, encodeId=85e21955e88fe, content=<a href='/topic/show?id=5b0b1022667b' target=_blank style='color:#2F92EE;'>#高危患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102266, encryptionId=5b0b1022667b, topicName=高危患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Mon Sep 06 10:53:10 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916970, encodeId=10f19169e0dc, content=<a href='/topic/show?id=0fac104144db' target=_blank style='color:#2F92EE;'>#小肠血管扩张症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104144, encryptionId=0fac104144db, topicName=小肠血管扩张症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Fri Jan 15 19:22:08 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916660, encodeId=04cb916660aa, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>一起加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/03/93ed59a42d72d285a4607ed046cd9736.jpg, createdBy=16ed2581300, createdName=薄荷糖OOO, createdTime=Thu Jan 14 22:26:14 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916638, encodeId=fe0091663851, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72fa2381620, createdName=12314969m72暂无昵称, createdTime=Thu Jan 14 21:36:30 CST 2021, time=2021-01-14, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1705687, encodeId=20eb1e0568783, content=<a href='/topic/show?id=ac7e89660ed' target=_blank style='color:#2F92EE;'>#血管扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89660, encryptionId=ac7e89660ed, topicName=血管扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cbe31021348, createdName=pyaili, createdTime=Wed Apr 07 20:53:10 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013562, encodeId=12b4201356248, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Oct 24 19:53:10 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684854, encodeId=0885168485451, content=<a href='/topic/show?id=794754e74f4' target=_blank style='color:#2F92EE;'>#扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54774, encryptionId=794754e74f4, topicName=扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=699d28086811, createdName=lsj637, createdTime=Sun Jan 17 20:53:10 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955788, encodeId=85e21955e88fe, content=<a href='/topic/show?id=5b0b1022667b' target=_blank style='color:#2F92EE;'>#高危患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102266, encryptionId=5b0b1022667b, topicName=高危患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Mon Sep 06 10:53:10 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916970, encodeId=10f19169e0dc, content=<a href='/topic/show?id=0fac104144db' target=_blank style='color:#2F92EE;'>#小肠血管扩张症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104144, encryptionId=0fac104144db, topicName=小肠血管扩张症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Fri Jan 15 19:22:08 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916660, encodeId=04cb916660aa, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>一起加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/03/93ed59a42d72d285a4607ed046cd9736.jpg, createdBy=16ed2581300, createdName=薄荷糖OOO, createdTime=Thu Jan 14 22:26:14 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916638, encodeId=fe0091663851, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72fa2381620, createdName=12314969m72暂无昵称, createdTime=Thu Jan 14 21:36:30 CST 2021, time=2021-01-14, status=1, ipAttribution=)]
    2021-10-24 zhaojie88
  3. [GetPortalCommentsPageByObjectIdResponse(id=1705687, encodeId=20eb1e0568783, content=<a href='/topic/show?id=ac7e89660ed' target=_blank style='color:#2F92EE;'>#血管扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89660, encryptionId=ac7e89660ed, topicName=血管扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cbe31021348, createdName=pyaili, createdTime=Wed Apr 07 20:53:10 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013562, encodeId=12b4201356248, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Oct 24 19:53:10 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684854, encodeId=0885168485451, content=<a href='/topic/show?id=794754e74f4' target=_blank style='color:#2F92EE;'>#扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54774, encryptionId=794754e74f4, topicName=扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=699d28086811, createdName=lsj637, createdTime=Sun Jan 17 20:53:10 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955788, encodeId=85e21955e88fe, content=<a href='/topic/show?id=5b0b1022667b' target=_blank style='color:#2F92EE;'>#高危患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102266, encryptionId=5b0b1022667b, topicName=高危患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Mon Sep 06 10:53:10 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916970, encodeId=10f19169e0dc, content=<a href='/topic/show?id=0fac104144db' target=_blank style='color:#2F92EE;'>#小肠血管扩张症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104144, encryptionId=0fac104144db, topicName=小肠血管扩张症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Fri Jan 15 19:22:08 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916660, encodeId=04cb916660aa, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>一起加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/03/93ed59a42d72d285a4607ed046cd9736.jpg, createdBy=16ed2581300, createdName=薄荷糖OOO, createdTime=Thu Jan 14 22:26:14 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916638, encodeId=fe0091663851, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72fa2381620, createdName=12314969m72暂无昵称, createdTime=Thu Jan 14 21:36:30 CST 2021, time=2021-01-14, status=1, ipAttribution=)]
    2021-01-17 lsj637
  4. [GetPortalCommentsPageByObjectIdResponse(id=1705687, encodeId=20eb1e0568783, content=<a href='/topic/show?id=ac7e89660ed' target=_blank style='color:#2F92EE;'>#血管扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89660, encryptionId=ac7e89660ed, topicName=血管扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cbe31021348, createdName=pyaili, createdTime=Wed Apr 07 20:53:10 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013562, encodeId=12b4201356248, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Oct 24 19:53:10 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684854, encodeId=0885168485451, content=<a href='/topic/show?id=794754e74f4' target=_blank style='color:#2F92EE;'>#扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54774, encryptionId=794754e74f4, topicName=扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=699d28086811, createdName=lsj637, createdTime=Sun Jan 17 20:53:10 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955788, encodeId=85e21955e88fe, content=<a href='/topic/show?id=5b0b1022667b' target=_blank style='color:#2F92EE;'>#高危患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102266, encryptionId=5b0b1022667b, topicName=高危患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Mon Sep 06 10:53:10 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916970, encodeId=10f19169e0dc, content=<a href='/topic/show?id=0fac104144db' target=_blank style='color:#2F92EE;'>#小肠血管扩张症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104144, encryptionId=0fac104144db, topicName=小肠血管扩张症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Fri Jan 15 19:22:08 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916660, encodeId=04cb916660aa, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>一起加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/03/93ed59a42d72d285a4607ed046cd9736.jpg, createdBy=16ed2581300, createdName=薄荷糖OOO, createdTime=Thu Jan 14 22:26:14 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916638, encodeId=fe0091663851, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72fa2381620, createdName=12314969m72暂无昵称, createdTime=Thu Jan 14 21:36:30 CST 2021, time=2021-01-14, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1705687, encodeId=20eb1e0568783, content=<a href='/topic/show?id=ac7e89660ed' target=_blank style='color:#2F92EE;'>#血管扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89660, encryptionId=ac7e89660ed, topicName=血管扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cbe31021348, createdName=pyaili, createdTime=Wed Apr 07 20:53:10 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013562, encodeId=12b4201356248, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Oct 24 19:53:10 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684854, encodeId=0885168485451, content=<a href='/topic/show?id=794754e74f4' target=_blank style='color:#2F92EE;'>#扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54774, encryptionId=794754e74f4, topicName=扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=699d28086811, createdName=lsj637, createdTime=Sun Jan 17 20:53:10 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955788, encodeId=85e21955e88fe, content=<a href='/topic/show?id=5b0b1022667b' target=_blank style='color:#2F92EE;'>#高危患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102266, encryptionId=5b0b1022667b, topicName=高危患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Mon Sep 06 10:53:10 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916970, encodeId=10f19169e0dc, content=<a href='/topic/show?id=0fac104144db' target=_blank style='color:#2F92EE;'>#小肠血管扩张症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104144, encryptionId=0fac104144db, topicName=小肠血管扩张症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Fri Jan 15 19:22:08 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916660, encodeId=04cb916660aa, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>一起加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/03/93ed59a42d72d285a4607ed046cd9736.jpg, createdBy=16ed2581300, createdName=薄荷糖OOO, createdTime=Thu Jan 14 22:26:14 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916638, encodeId=fe0091663851, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72fa2381620, createdName=12314969m72暂无昵称, createdTime=Thu Jan 14 21:36:30 CST 2021, time=2021-01-14, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1705687, encodeId=20eb1e0568783, content=<a href='/topic/show?id=ac7e89660ed' target=_blank style='color:#2F92EE;'>#血管扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89660, encryptionId=ac7e89660ed, topicName=血管扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cbe31021348, createdName=pyaili, createdTime=Wed Apr 07 20:53:10 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013562, encodeId=12b4201356248, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Oct 24 19:53:10 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684854, encodeId=0885168485451, content=<a href='/topic/show?id=794754e74f4' target=_blank style='color:#2F92EE;'>#扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54774, encryptionId=794754e74f4, topicName=扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=699d28086811, createdName=lsj637, createdTime=Sun Jan 17 20:53:10 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955788, encodeId=85e21955e88fe, content=<a href='/topic/show?id=5b0b1022667b' target=_blank style='color:#2F92EE;'>#高危患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102266, encryptionId=5b0b1022667b, topicName=高危患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Mon Sep 06 10:53:10 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916970, encodeId=10f19169e0dc, content=<a href='/topic/show?id=0fac104144db' target=_blank style='color:#2F92EE;'>#小肠血管扩张症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104144, encryptionId=0fac104144db, topicName=小肠血管扩张症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Fri Jan 15 19:22:08 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916660, encodeId=04cb916660aa, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>一起加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/03/93ed59a42d72d285a4607ed046cd9736.jpg, createdBy=16ed2581300, createdName=薄荷糖OOO, createdTime=Thu Jan 14 22:26:14 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916638, encodeId=fe0091663851, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72fa2381620, createdName=12314969m72暂无昵称, createdTime=Thu Jan 14 21:36:30 CST 2021, time=2021-01-14, status=1, ipAttribution=)]
    2021-01-14 薄荷糖OOO

    #学习#一起加油

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1705687, encodeId=20eb1e0568783, content=<a href='/topic/show?id=ac7e89660ed' target=_blank style='color:#2F92EE;'>#血管扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89660, encryptionId=ac7e89660ed, topicName=血管扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cbe31021348, createdName=pyaili, createdTime=Wed Apr 07 20:53:10 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013562, encodeId=12b4201356248, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Oct 24 19:53:10 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684854, encodeId=0885168485451, content=<a href='/topic/show?id=794754e74f4' target=_blank style='color:#2F92EE;'>#扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54774, encryptionId=794754e74f4, topicName=扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=699d28086811, createdName=lsj637, createdTime=Sun Jan 17 20:53:10 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955788, encodeId=85e21955e88fe, content=<a href='/topic/show?id=5b0b1022667b' target=_blank style='color:#2F92EE;'>#高危患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102266, encryptionId=5b0b1022667b, topicName=高危患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Mon Sep 06 10:53:10 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916970, encodeId=10f19169e0dc, content=<a href='/topic/show?id=0fac104144db' target=_blank style='color:#2F92EE;'>#小肠血管扩张症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104144, encryptionId=0fac104144db, topicName=小肠血管扩张症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Fri Jan 15 19:22:08 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916660, encodeId=04cb916660aa, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>一起加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/03/93ed59a42d72d285a4607ed046cd9736.jpg, createdBy=16ed2581300, createdName=薄荷糖OOO, createdTime=Thu Jan 14 22:26:14 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916638, encodeId=fe0091663851, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72fa2381620, createdName=12314969m72暂无昵称, createdTime=Thu Jan 14 21:36:30 CST 2021, time=2021-01-14, status=1, ipAttribution=)]
    2021-01-14 12314969m72暂无昵称

    0

相关资讯

赵志青:颈动脉狭窄支架术后再狭窄的原因分析及处理

颈动脉术后再狭窄目前还未有最佳治疗方式,需要根据经验以及个体差异制定治疗方案。目前,CEA是CAS术后再狭窄的首选治疗方案。DCB联合CAS、DES可能会是未来颈动脉术后再狭窄腔内治疗的趋势。

Heart:心血管疾病和危险因素对COVID-19患者致命性结局的影响

该荟萃分析的结果表明,对于所有年龄段的患者,CVD及其危险因素(高血压和糖尿病)与COVID-19的致命性结局密切相关。

J INTERN MED:LDL-胆固醇水平是1型糖尿病儿童和成人视网膜病变和肾病的危险因素

高LDL-胆固醇水平的1型糖尿病年轻人视网膜病变和肾病风险增加,而与血糖和其他已确定的血管并发症危险因素无关。

JNNP:视神经脊髓炎谱系疾病:与妊娠有关的发作和预测危险因素

视神经脊髓炎谱系障碍(NMOSD)反映了自身抗体诱导的中枢神经系统(CNS)炎症性疾病的分类,主要涉及视神经、脊髓,血清中存在致病性水通道蛋白-4抗体(AQP4-ab)对NMOSD具有高度特异性,在大